hit counter

How Long Does Wellbutrin Stay In Your System?

Wellbutrin (Bupropion) is an antidepressant that is hypothesized to function as a norepinephrine-dopamine reuptake inhibitor (NDRI).  It is believed to predominantly increase levels of norepinephrine and only affects dopamine to a minor extent.  As a result of its noradrenergic mechanism of action, it is considered “atypical” when compared to other serotonergic antidepressants. Unlike serotonergic antidepressants, Wellbutrin has a …

Read more

How Long Does Pristiq Stay In Your System After Stopping?

Pristiq (Desvenlafaxine) is an SNRI antidepressant developed by Wyeth as an improved successor to the older drug Effexor (Venlafaxine).  Pristiq is engineered to contain solely the pharmacologically active metabolite of Venlafaxine known as “O-desmethylvenlafaxine” in a synthetic format dubbed “desvenlafaxine.”  The drug was approved by the FDA in 2008 for the treatment of major depression …

Read more

How Long Does Trazodone Stay In Your System After Stopping?

Trazodone (brand name “Desyrel”) is a medication originally approved by the FDA in 1981 for the treatment of anxiety disorder and major depressive disorder.  It is also commonly utilized as a sleep-inducing agent in cases of insomnia, as well as an off-label option for conditions such as: alcohol withdrawal, bulimia nervosa, fibromyalgia, neuropathy, OCD, panic …

Read more

Does Lexapro (Escitalopram) Cause Hair Loss or Thinning?

It’s no secret that many people derive therapeutic benefit from the serotonergic antidepressant Escitalopram, marketed under the brand name “Lexapro.”  However some Lexapro users have become increasingly frustrated with its side effect profile.  One side effect in particular that is often reported by users, yet infrequently reported by its manufacturer (Forest Laboratories) – is that …

Read more

How Long Does Effexor Stay In Your System After Stopping It?

Effexor (Venlafaxine) is a SNRI (serotonin-norepinephrine reuptake inhibitor) medication prescribed primarily for the treatment of major depressive disorder.  It was initially introduced to the market by Wyeth in 1993 when it became the first dual-reuptake inhibitor to attain FDA approval for depression.  It differed from the SSRIs in that in addition to solely inhibiting reuptake …

Read more